- Joined
- Nov 13, 2012
- Messages
- 127
- Reaction score
- 58
- Points
- 4,736
Are your centers doing SBRT prostate boost (after 50.4-54Gy to the prostate/Sv +/- lymphatics)?
Dose/fractionation?
What are your patient selection criteria?
Any specific simulation parameters?
Billing/reimbursement issues with this?
ProAre your centers doing SBRT prostate boost (after 50.4-54Gy to the prostate/Sv +/- lymphatics)?
Dose/fractionation?
What are your patient selection criteria?
Any specific simulation parameters?
Billing/reimbursement issues with this?
I disagree. They clearly are enthusiastic about it; essentially accepting "slightly worse" because it is easier (in the sentence you highlighted). I think the con editorial provides the appropriate context.The paper you cite as "Pro" reviews the literature but does not really advocate for SBRT boost.
"SBRT boost should ideally be validated in clinical trials. Even if it becomes evident that the results are slightly worse than HDR, SBRT is technically less complex for practitioners and may be preferable to patients."
So back to my original question...
I know a lot of people are doing this in the community.
Is this not the case?
So back to my original question...
I know a lot of people are doing this in the community.
Is this not the case?
Medicare is pretty lenient for shenanigans like protons or sbrt boost for prostate. In our area I've also heard of savi/mammosite being used and billed as a boost. Outside of that, commercial/hmo will frown on it.
In the freestanding setting, sbrt for definitive prostate did not reimburse for years, even for Medicare
Oh I agree. It's just that they won't necessarily require auth or deny payment like other payors do and I get a sense that is where most of these patients are coming from"Leniency" might be an incorrect impression. Medicare can come back months or years later and say they want their $ back because the treatment was not necessary. I am no expert on this, but I don't think written policies differentiate necessity based on whether or not a facility is freestanding. It may be that a hospital-based practice negotiated with local insures (as many proton centers do).
Although conceptually correct, there is a difference between the two. You can cure most prostate cancer patients with EBRT only. You cannot claim the same for cervix cancer patients.Conceptually, just like with cervical cancer, I think brachy boost should ultimately win.